PALONOSETRON, Jakavi 10 mg tablets, ONDANSETRON, NETUPITANT, APREPITANT, PACRITINIB, Jakavi 5 mg tablets, SELINEXOR
XPORT-MF-044
Phase 2 small_molecule active
Quick answer
PALONOSETRON, Jakavi 10 mg tablets, ONDANSETRON, NETUPITANT, APREPITANT, PACRITINIB, Jakavi 5 mg tablets, SELINEXOR for moderate thrombocytopenia, JAK inhibitor-naïve myelofibrosis is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- moderate thrombocytopenia, JAK inhibitor-naïve myelofibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active